Skip to Content

Join the 'Anemia Associated with Chronic Renal Failure' group to help and get support from people like you.

Anemia Associated with Chronic Renal Failure News

Coming Soon: A Wearable Artificial Kidney?

Posted 7 Jun 2016 by Drugs.com

TUESDAY, June 7, 2016 - Someday, dialysis patients might free themselves of clunky machines, moving about with a "wearable artificial kidney" instead. That's the promise of a new clinical trial that suggests this type of technology is finally within reach. "This would be a game changer," said one kidney specialist, Dr. Maria DeVita. "The fact that clinical trials are beginning gives us all hope that we will have a significant improvement in the care of those patients requiring ongoing hemodialysis." DeVita is associate director of nephrology at Lenox Hill Hospital in New York City. People with advanced kidney disease must often resort to spending hours a day at dialysis centers, with special machines cleansing their blood as their kidneys once did. The dream has long been a small portable device that could perform dialysis as patients went about their usual day. That dream may be ... Read more

Related support groups: Renal Failure, Chronic Kidney Disease, Diabetic Kidney Disease, Nephrotic Syndrome, Peritoneal dialysis, Hemodialysis, Diabetic Nephropathy, Anemia Associated with Chronic Renal Failure, Polycystic Kidney Disease, Diagnosis and Investigation, Renal Osteodystrophy, Hemodialysis Anticoagulation, Renal and Genitourinary Disorders, Alport Syndrome, Hyperphosphatemia of Renal Failure, Anuria, Hypertensive Renal Disease

Smoking Harms Black Americans' Kidneys, Study Suggests

Posted 25 May 2016 by Drugs.com

WEDNESDAY, May 25, 2016 – Smoking may pose a significant risk to kidney health for black Americans, new research suggests. The study included more than 3,600 black adults, aged 21 to 84, from Jackson, Miss., and the surrounding area. The researchers followed their health for 12 years. During that time, the researchers found that, overall, study participants who were current smokers had an 83 percent greater decline in kidney function than those who never smoked. The more a person smoked, the greater their rate of kidney decline, the findings showed. People who smoked up to 19 cigarettes a day had a 75 percent greater decline in kidney function. People who had 20 or more cigarettes a day had a 97 percent greater decline in kidney function, the study found. Though the study wasn't designed to prove cause-and-effect, the researchers said that current smokers had 38 percent higher ... Read more

Related support groups: Smoking, Smoking Cessation, Renal Failure, Chronic Kidney Disease, Prevention of Cardiovascular Disease, Cardiovascular Risk Reduction, Anemia Associated with Chronic Renal Failure, Nephropathy, Renal and Genitourinary Disorders

High-Salt Diets May Raise Heart Risks for Kidney Patients

Posted 24 May 2016 by Drugs.com

TUESDAY, May 24, 2016 – People with chronic kidney disease face higher odds of heart attack or stroke if they have high-salt diets, a new study suggests. "Moderate sodium reduction among patients with chronic kidney disease and high sodium intake may lower [heart] risk," concluded a team led by Dr. Jiang He, of Tulane University in New Orleans. About one in every 10 Americans is affected by chronic kidney disease, and more than one-third of U.S. adults have heart disease, the researchers noted. The role of daily salt intake in kidney patients – and its effect on heart risk – hasn't been clear, however. To learn more, the investigators looked at outcomes for almost 3,800 patients with chronic kidney disease at seven locations across the United States. The patients provided urine samples to researchers at the beginning of the study in 2003, and then once a year over the next two years. ... Read more

Related support groups: Ischemic Stroke, Heart Attack, Renal Failure, Transient Ischemic Attack, Myocardial Infarction, Chronic Kidney Disease, Sodium Chloride, Diabetic Kidney Disease, Ischemic Stroke - Prophylaxis, Diabetic Nephropathy, Peritoneal dialysis, Hemodialysis, Anemia Associated with Chronic Renal Failure, HalfLytely and Bisacodyl, Hematuria, Hyper-Sal, Rhinaris, Myocardial Infarction - Prophylaxis, Saline Nasal Mist, Thermotabs

Medicare Spends Billions on Chronic Kidney Disease, Study Finds

Posted 29 Mar 2016 by Drugs.com

TUESDAY, March 29, 2016 – Chronic kidney disease affects nearly 14 percent of Americans and costs Medicare billions of dollars a year, a new study reveals. In 2013, Medicare spent $50 billion on chronic kidney disease among people 65 and older, and $31 billion on those with kidney failure, the researchers found. "This report is a one-stop shop to try to understand the prevalence of kidney disease, how it's being treated and how the burden affects various populations," researcher Rajesh Balkrishnan, a professor of public health sciences at the University of Virginia School of Medicine, said in a university news release. "If we can identify which treatment modalities are working and how they're used and link these treatments to outcomes, we can inform the government of the most cost-effective ways to manage and treat the growing burden of kidney disease in the U.S.," he added. The study ... Read more

Related support groups: Renal Failure, Chronic Kidney Disease, Diabetic Kidney Disease, Diabetic Nephropathy, Peritoneal dialysis, Anemia Associated with Chronic Renal Failure, Renal Osteodystrophy, Renal and Genitourinary Disorders, Hypertensive Renal Disease, Renovascular Hypertension, Anuria, Hyperphosphatemia of Renal Failure, Hypertensive Heart (w/ CHF) and Renal Disease, Renal Artery Atherosclerosis

Do Taller Patients Fare Worse on Dialysis?

Posted 1 Oct 2015 by Drugs.com

THURSDAY, Oct. 1, 2015 – Tallness may be linked with an increased risk for premature death in kidney failure patients on dialysis, a new study suggests. While the researchers only found an association and not a cause-and-effect link, tall people on dialysis appeared to have higher rates of premature death than people in the general population. The risk was higher in men than in women, and among patients with shorter dialysis treatment times, the researchers said. The researchers analyzed data from just over 1 million Americans who began dialysis between 1995 and 2008 and were followed for up to five years. Being tall was associated with increased risk of premature death among dialysis patients who were American Indian/Alaska natives, Asians and whites, but this was not the case among black patients in the study. Tall black dialysis patients' risk of premature death was the same as in ... Read more

Related support groups: Renal Failure, Chronic Kidney Disease, Diabetic Kidney Disease, Diabetic Nephropathy, Hemodialysis, Anemia Associated with Chronic Renal Failure, Anuria, Hemodialysis Anticoagulation, Renal and Genitourinary Disorders

Kidney Problems Linked to Brain Disorders: Study

Posted 6 Aug 2015 by Drugs.com

THURSDAY, Aug. 6, 2015 – Kidney problems can increase the risk of brain disorders, a new study finds. The findings suggest that protecting kidney health may also benefit the brain, the researchers said. They studied data from more than 2,600 people in the Netherlands, and found that poor kidney function was strongly associated with decreased blood flow to the brain. They also saw an increased risk of stroke and memory and thinking problems (dementia) in people with kidney problems. The association was independent of known heart disease risk factors, the researchers said. The study was published Aug. 6 in the Journal of the American Society of Nephrology. "Our findings provide a possible explanation linking kidney disease to brain disease," Dr. M. Arfan Ikram, an assistant professor of neuroepidemiology at Erasmus University Medical Center in the Netherlands, said in a journal news ... Read more

Related support groups: Dementia, Renal Failure, Alzheimer's Disease, Kidney Infections, Chronic Kidney Disease, Mild Cognitive Impairment, Diabetic Kidney Disease, Peritoneal dialysis, Diabetic Nephropathy, Anemia Associated with Chronic Renal Failure, Polycystic Kidney Disease, Pyelonephritis, Renal Osteodystrophy, Hyperphosphatemia of Renal Failure, Renal Vein Thrombosis, Lewy Body Dementia, Renal and Genitourinary Disorders, Renovascular Hypertension

FDA Approves Triferic for Iron Replacement and Maintenance of Hemoglobin in Hemodialysis Patients

Posted 26 Jan 2015 by Drugs.com

WIXOM, Mich., January 26, 2015 (GLOBE NEWSWIRE) – Rockwell Medical, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis, announced today that the U.S. Food & Drug Administration (FDA) has approved its drug Triferic for commercial sale as an iron replacement product to maintain hemoglobin in adult patients with hemodialysis dependent chronic kidney disease. "We are extremely pleased with the FDA approval of Triferic. It is the first drug approved to replace ongoing iron losses and to maintain hemoglobin levels in hemodialysis patients," stated Robert L. Chioini, Founder, Chairman and Chief Executive Officer of Rockwell. "Triferic's unique ability to be delivered via dialysate ... Read more

Related support groups: Anemia Associated with Chronic Renal Failure

Omontys Approved for Anemic People With Kidney Disease

Posted 27 Mar 2012 by Drugs.com

TUESDAY, March 27 – Omontys (peginesatide) has been approved by the U.S. Food and Drug Administration to treat anemia in adults who require dialysis due to chronic kidney disease. Anemia is characterized by a lack of enough healthy red blood cells. The newly approved drug is designed to stimulate bone marrow to produce more of these cells, reducing a person's need for a blood transfusion, the FDA said Tuesday in a news release. Clinical testing of the once-monthly injection involved 1,608 people with abnormally low hemoglobin, a measure of anemia. The most common side effects were diarrhea, vomiting, high blood pressure and pain in the joints, back, legs or arms, the agency said. Omontys should not be used in people with chronic kidney disease who are not on dialysis, nor those with cancer-related anemia, the FDA warned. It should also not be used as a substitute in people who require ... Read more

Related support groups: Anemia Associated with Chronic Renal Failure

Affymax and Takeda Announce FDA Approval of Omontys (peginesatide) Injection for the Treatment of Anemia Due to Chronic Kidney Disease (CKD) in Adult Patients on Dialysis

Posted 27 Mar 2012 by Drugs.com

PALO ALTO, Calif. & OSAKA, Japan--(BUSINESS WIRE)--Mar 27, 2012 - Affymax, Inc. and Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration (FDA) approved Omontys (peginesatide) Injection for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis. Omontys is the only once-monthly erythropoiesis-stimulating agent (ESA) for anemia to be made available to the dialysis patient population in the United States. The FDA's decision was based on a New Drug Application (NDA), which included results from two randomized, controlled, open-label, Phase 3 studies (EMERALD 1 and 2) that demonstrated the safety and efficacy of Omontys dosed once monthly, compared to epoetin dosed between one-to-three times per week (according to product labels), in maintaining hemoglobin (Hb) levels in anemic CKD patients on dialysis. In these ... Read more

Related support groups: Anemia Associated with Chronic Renal Failure

For Some on Dialysis, Anemia Drugs Pose Risks

Posted 2 Mar 2010 by Drugs.com

TUESDAY, March 2 – Powerful drugs that treat the anemia caused by kidney failure yield mixed results, depending on the severity of the anemia, a new study has shown. People on dialysis with severe anemia, according to the study, tend to live longer when given high doses of the drugs – known as erythropoiesis-stimulating agents (ESAs) and marketed as Epogen, Procrit and Aranesp. But it found that the drugs increase the risk for dying prematurely among people with mild anemia. ESAs, which increase the production of red blood cells, are approved by the U.S. Food and Drug Administration to treat the anemia caused by cancer chemotherapy and AIDS drugs as well as kidney failure. But safety concerns have limited their use, especially among cancer patients. Over the next few months, the FDA and the U.S. Centers for Medicare and Medicaid Services plan to review the use of ESAs in the treatment ... Read more

Related support groups: Aranesp, Procrit, Epogen, Anemia Associated with Chronic Renal Failure, Darbepoetin Alfa, Mircera, Epoetin Beta-Methoxy Polyethylene Glycol, Epoetin Alfa

Ask a Question

Further Information

Related Condition Support Groups

Renal and Genitourinary Disorders

Related Drug Support Groups

ferrous sulfate, ferrous fumarate, ferrous gluconate, Aranesp, Procrit, Epogen, iron dextran, Feraheme, Durabolin, view more... Infed, darbepoetin alfa, Deca-Durabolin, ferumoxytol, Mircera, Ferralet, Hemocyte, Durabolin 50, Lydia E. Pinkham, Ferrocite, Proferrin-ES, Fergon, epoetin beta-methoxy polyethylene glycol, nandrolone, heme iron polypeptide, Nephro-Fer, Hemaspan, Vitron-C-Plus, Triferic, Hemocyte-C, Ferrimin 150, Omontys, Ircon, Iron Fumarate, Iron Sulfate, Fer-Iron, Nulecit, Ferrousal, Iron Gluconate, Hybolin Decanoate, Feosol Original, Dexferrum, Ferrlecit, FE-40, ferric pyrophosphate citrate, epoetin alfa, sodium ferric gluconate complex, peginesatide, Feostat, Hybolin-Improved, Simron, Ferate, Femiron, Andryl 200, Androlone-D, ascorbic acid / ferrous fumarate, Anabolin LA, Fumasorb